Cosmos Health (COSM) Net Shares Issued and Repurchased (2017 - 2024)
Cosmos Health's (COSM) quarterly Net Shares Issued and Repurchased came in at $509096.0 in Q4 2024, up 9492.92% on a YoY basis from $5307.0 in Q1 2024, and up 16343.67% quarter-over-quarter from $3096.0 in Q1 2024.
Analysis
Cosmos Health (COSM) Net Shares Issued and Repurchased (2017 - 2024) Analysis & Trends
Cosmos Health (COSM) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $509096.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Net Shares Issued and Repurchased rose 9492.92% year-over-year to $509096.0; the trailing twelve-month figure through Dec 2024 stood at $509096.0 (up 9492.92% YoY), and the FY2024 full-year result was $509096.0, up 9492.92% from the prior year.
- Net Shares Issued and Repurchased improved to $509096.0 in Q4 2024 per COSM's latest filing, from $3096.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $5.8 million in Q1 2022 and bottomed at $3096.0 in Q1 2024.
- Historically, Net Shares Issued and Repurchased has averaged $1.1 million across 4 years, with a median of $15153.5 in 2021.
- The sharpest annual moves came in 2022 and 2024: Net Shares Issued and Repurchased tumbled 78.77% in 2022, then soared 9492.92% in 2024.
- Over 4 years, Net Shares Issued and Repurchased stood at $25000.0 in 2021, then sank by 78.77% to $5307.0 in 2022, then changed by 0.0% to $5307.0 in 2023, then jumped by 9492.92% to $509096.0 in 2024.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $509096.0, $3096.0, and $5307.0 for Q4 2024, Q1 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 31,000.00 |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 509,096.00 |
| Mar 31, 2024 | 3,096.00 |
| Dec 31, 2023 | 5,307.00 |
| Dec 31, 2022 | 5,307.00 |
| Mar 31, 2022 | 5.79 Mn |
| Dec 31, 2021 | 25,000.00 |
| Dec 31, 2018 | 910,078.00 |
| Dec 31, 2017 | 96,000.00 |